Good science and the marketplace for drugs: a conversation with Jean-Pierre Garnier. Interview by John K. Iglehart.
Garnier
Jean-Pierre
JP
GlaxoSmithKline.
D000368:Aged; D003362:Cost-Benefit Analysis; D003906:Developing Countries; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics / Q000458:organization & administration*; D016568:Drugs, Generic; D019981:Health Care Sector; D006801:Humans; D007356:Insurance, Pharmaceutical Services; D006278:Medicare; D012106:Research; D014481:United States; D014612:Vaccines
D016568:Drugs, Generic; D014612:Vaccines